Another Good Week for Biopharma and Diagnostics Stocks: Innovation is Driving Gains
April 27, 2020 at 04:23 AM EDT
As the market moves with COVID epidemiological data many stocks took a hit on questionable or incomplete news from the WHO on a clinical study in China on Remdesivir; Gilead Sciences stock took a hit on Thursday from $82 but recovered Friday at $79.